- Home
- / NATCO Pharma
NATCO Pharma
Stock Price
₹848.5
2023-09-25
Market Capitalization
₹156.6 B
2023-09-25
Revenue
₹27.1 B
FY, 2023
NATCO Pharma Summary
Company Summary
- Overview
- NATCO Pharma is a company focused on research, manufacturing, and marketing of finished dosage formulations (FDF) and active pharmaceutical ingredients (API). It specializes in generic oncology.
- Type
- Public
- Status
- Active
- Founded
- 1981
- HQ
- Hyderabad, IN | view all locations
- Cybersecurity rating
- ESG rating
Table of Contents
Key People
Leela Digumarti, Independent Director
M.u.r Naidu, Independent Director
Linga Rao, President - Technical Affairs
LocationsView all
7 locations detected
Hyderabad, Telangana HQ
India
Natco House, Road No-2, Banjara Hills, Park View Enclave, Jubilee Hills
Central Hope Town, UK
India
Pharma City Rd
Chennai, TN
India
Tpp salai, 74/7b, SH 104, Vaikkadu, Block 270 Manali New Town, Manali
Hyderabad, TG
India
Unnamed Road, Sanath Nagar IE, Sanath Nagar
Santola, AS
India
Mirza Chowk, Mirza
Vijayapuri North, TG
India
H8M7+X6P
NATCO Pharma Financials
Summary Financials
- Revenue (Q1, 2024)
- ₹11.4B
- Gross profit (Q1, 2024)
- ₹9.6B
- Net income (Q1, 2024)
- ₹4.2B
- Cash (FY, 2023)
- ₹5.5B
- EBIT (Q1, 2024)
- ₹5.0B
- Enterprise value
- $152.9B